Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
CYCURION INC (CYCU)
NASDAQInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
$2.24-11.11%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologyInformation Technology ServicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for CYCU yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Raise capital through equity and convertible securities | A supporting condition in CYCURION INC's published investment case. The stated target is Sufficient capital raised to fund operations and growth. | Intact | Capital raising fails and liquidity tightens within 1 year | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making growth and execution story, not an established compounder. The long-term thesis is on watch: revenue rose between the two reported 2026 quarters, but operating income stayed negative and the recent business performance remains below its industry cohort.
The valuation signal has improved from restrictive to cautious, and the model shows CYCU at a premium to peers. The expectations gap is negative, while the overall pricing signal is described as justified and fragility is low; confidence in the valuation model is also low.
Near term, contract execution could support revenue growth, but the company has not yet reached its stated break-even and positive operating cash-flow milestone. Erratic earnings surprises and a 52% estimated miss probability make the next report worth watching, especially for any guidance cut. Product commercialization is a stated priority, but the supplied figures do not yet show product adoption or revenue.
The multi-year thesis hinges on continued revenue growth translating into better margins, and eventually positive operating cash flow. A guidance cut would be a meaningful negative; rate cuts or stabilization among major technology peers could provide a more supportive sector backdrop. Recent officer and director changes, along with the termination of a material agreement, add context, but the supplied evidence does not establish their business impact.
Over the next 1 to 3 years, CYCU remains an uncertain execution story: the revenue trend is encouraging, but losses, volatile management signals, and high risk leave the thesis dependent on clearer progress toward break-even. The evidence supports a watchful, cautious long-term thesis. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in CYCURION INC's published investment case. The stated target is Complete restructuring agreements with noteholders. |
| Intact |
| Debt restructuring fails or worsens liquidity within 1 year |
Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue reaches $21.5 million by March 2027 | Revenue may reach $21.5 million by March 2027. | Intact | Revenue falls below $21 million by March 2027 | Revenue: $3.757M FY2026-Q2; GAAP. Published target: 21.5 USD_MILLIONS. Target period ends 2027-03-31; this observation covers 2026-Q2. Aug 14, 20263,757,076 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows to $40 million by end 2026 | It aims to grow revenue to $40 million by end 2026. | Broken | Revenue falls below $30 million by end 2026 | Revenue: $3.757M FY2026-Q2; GAAP. Published target: 40 USD_MILLIONS. Target period ends 2026-12-31; this observation covers 2026-Q2. Aug 14, 20263,757,076 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-1.73 → $-1.84 · observed estimates
$0.02B → $0.03B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-07-25 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-07-26 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-07-27 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-07-28 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-07-29 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-07-30 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-07-31 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-01 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-02 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-03 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-04 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-05 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-06 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-07 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-08 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-09 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-10 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-11 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-12 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-13 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-14 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-15 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-16 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-17 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-18 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-19 | $-1.73 | $17,776,000 | 1 / 1 |
| 2026-08-20 | $-0.23 | $28,600,000 | 1 / 1 |
| 2026-08-21 | $-0.23 | $28,600,000 | 1 / 1 |
| 2026-08-22 | $-0.23 | $28,600,000 | 1 / 1 |
| 2026-08-23 | $-0.23 | $28,600,000 | 1 / 1 |
| 2026-08-24 | $-0.23 | $28,600,000 | 1 / 1 |
| 2026-08-25 | $-0.23 | $28,600,000 | 1 / 1 |
| 2026-08-26 | $-0.23 | $28,600,000 | 1 / 1 |
| 2026-08-27 | $-0.23 | $28,600,000 | 1 / 1 |
| 2026-08-28 | $-0.23 | $28,600,000 | 1 / 1 |
| 2026-08-29 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-08-30 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-08-31 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-01 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-02 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-03 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-04 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-05 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-06 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-07 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-08 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-09 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-10 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-11 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-12 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-13 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-14 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-15 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-16 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-17 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-18 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-19 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-20 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-21 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-22 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-23 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-24 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-25 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-26 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-27 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-28 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-29 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-09-30 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-01 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-02 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-03 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-04 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-05 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-06 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-07 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-08 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-09 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-10 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-11 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-12 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-13 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-14 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-15 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-16 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-17 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-18 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-19 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-20 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-21 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-22 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-23 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-24 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-25 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-26 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-27 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-28 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-29 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-30 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-10-31 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-11-01 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-11-02 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-11-03 | $-1.84 | $28,600,000 | 1 / 1 |
| 2026-11-04 | $-1.84 | $28,600,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 16, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.